In this study, we have substantiated the detailed mechanisms for endocytosis of the ligand-induced activated form of EGFR, i.e., pEGFR, via the early/late endocytic pathway in both NSCLC cell lines, i.e., PC9 and QG56 cell lines. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.